Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04261439 |
| Title | A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ITA | ESP | DEU | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope National Medical | Duarte | California | 91010 | United States | Details | |
| Moores UCSD Cancer Center | La Jolla | California | 92093 | United States | Details | |
| Novartis Investigative Site | Leuven | 3000 | Belgium | Details | ||
| Novartis Investigative Site | Essen | 45147 | Germany | Details | ||
| Novartis Investigative Site | Napoli | 80131 | Italy | Details | ||
| Novartis Investigative Site | Chuo ku | Tokyo | 104 0045 | Japan | Details | |
| Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details | |
| Novartis Investigative Site | Madrid | 28009 | Spain | Details | ||
| Novartis Investigative Site | Taipei | 10048 | Taiwan | Details |